A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing

Ryuya Murai1, Yoko Yoshida1, Teruyuki Muraguchi1

  • 1Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Oncotarget
|February 10, 2011
PubMed

Insights

The RECK protein, a cancer suppressor, can be reactivated by certain compounds. Disulfiram, an identified compound, significantly reduced lung metastasis in preclinical cancer models.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • RECK (Reversion-Inducing Cysteine-Rich Protein-rich protein) is a membrane-anchored metalloproteinase regulator frequently downregulated in cancers.
  • Low RECK levels in tumors correlate with poor prognosis, while its forced expression inhibits cancer progression in models.
  • RECK is a potential biomarker for benignancy and a therapeutic target in cancer treatment.

Purpose of the Study:

  • To develop and validate a screening system for identifying compounds that can restore RECK expression in cancer cells.
  • To evaluate the therapeutic potential of RECK-inducing compounds in preclinical cancer models.

Main Methods:

  • Established a dual-transgene cell line with a RECK promoter-SEAP reporter and a Tet-off regulated HRAS(12V) oncogene.
  • Screened 880 bioactive compounds for RECK promoter activation in both transformed and untransformed cells.
  • Validated selected compounds for their ability to upregulate endogenous RECK protein and suppress metastasis in vivo.

Main Results:

  • Identified 34 compounds activating the RECK promoter, including 10 known anticancer drugs.
  • Four compounds demonstrated upregulation of endogenous RECK protein in human cancer cell lines.
  • Disulfiram, a top-ranked compound, significantly suppressed spontaneous lung metastasis of fibrosarcoma cells in mice.

Conclusions:

  • The developed cell line is effective for screening RECK-inducing compounds.
  • Disulfiram shows significant preclinical efficacy in suppressing cancer metastasis.
  • This screening approach holds promise for discovering novel cancer therapeutics targeting RECK.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...